Rainard F.
- Country
- Germany
- Department
- 001: Early Phase Clinical Unit Berlin
Research Overview
- Evaluation of Safety, Tolerability, and Immunological Response of ASP2390 in Adults with House Dust Mite Allergy
- Evaluation of the Impact of Tolinapant (ASTX660) on OCT1, OCT2, and MATE1 Substrate Pharmacokinetics in Healthy Volunteers
- A Double Blind, Multicentre, Randomised Three-Period, Three-Treatment, Cross-Over Study To Evaluate The Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters In Participants with Chronic Obstructive Pulmonary Disease (ATHLOS)
Data & Insights
Has run more than one trial at 1 of 10 partner sites.
Specializations
Respiratory Medicine
This investigator demonstrates significant expertise in chronic obstructive pulmonary disease (COPD) research, particularly focusing on innovative inhalation therapies and treatment approaches.
- COPD Treatment Evaluation
- Dynamic Hyperinflation Assessment
- Metered Dose Inhaler Studies
Special interest in evaluating combination therapies including budesonide, glycopyrronium, and formoterol fumarate delivery systems.
Allergology
The investigator specializes in various allergic conditions, conducting research on both seasonal and perennial allergies.
- Grass Pollen Allergy Studies
- House Dust Mite Allergy Research
- Novel Allergy Treatments
Focuses on immunological responses and innovative therapeutic approaches for allergic conditions.
Clinical Pharmacology
Extensive experience in conducting first-in-human studies and pharmacological research with healthy volunteers.
- Safety and Tolerability Assessments
- Pharmacokinetic Studies
- Drug Transportation Research
Particular expertise in evaluating novel compounds and their interactions with cellular transporters.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.